Column Group

Latest statistics and disclosures from Column Group's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are TNYA, ORIC, NGM, RAPT, Surrozen, and represent 99.94% of Column Group's stock portfolio.
  • Added to shares of these 1 stock: SGMT.
  • Started 1 new stock position in SGMT.
  • Reduced shares in these 2 stocks: ORIC, Surrozen.
  • Column Group was a net seller of stock by $-458k.
  • Column Group has $161M in assets under management (AUM), dropping by 6.05%.
  • Central Index Key (CIK): 0001833486

Tip: Access up to 7 years of quarterly data

Positions held by Column Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Column Group

Column Group holds 7 positions in its portfolio as reported in the March 2024 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Tenaya Therapeutics (TNYA) 30.6 $49M 9.4M 5.23
 View chart
Oric Pharmaceuticals (ORIC) 30.3 $49M 3.5M 13.75
 View chart
Ngm Biopharmaceuticals (NGM) 18.0 $29M 18M 1.59
 View chart
Rapt Therapeutics (RAPT) 15.0 $24M 2.7M 8.98
 View chart
Surrozen 6.0 $9.7M 617k 15.71
 View chart
Sagimet Biosciences Inc-a (SGMT) 0.1 $93k NEW 17k 5.42
 View chart
Revolution Medicines (RVMD) 0.0 $1.5k 46.00 32.24
 View chart

Past Filings by Column Group

SEC 13F filings are viewable for Column Group going back to 2020